The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-fluoro-N-benzyl-D-galactonoamidine ID: ALA3359667
PubChem CID: 136078852
Max Phase: Preclinical
Molecular Formula: C13H17FN2O4
Molecular Weight: 284.29
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: OC[C@H]1N/C(=N\Cc2ccccc2F)[C@H](O)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C13H17FN2O4/c14-8-4-2-1-3-7(8)5-15-13-12(20)11(19)10(18)9(6-17)16-13/h1-4,9-12,17-20H,5-6H2,(H,15,16)/t9-,10+,11+,12-/m1/s1
Standard InChI Key: KBVBVWYAKQVNNW-NOOOWODRSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
25.5723 -3.3843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5723 -4.2015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2776 -4.6060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9829 -4.2015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9829 -3.3843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2776 -2.9716 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.6918 -2.9778 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.6900 -4.6111 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.2776 -5.4232 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.8652 -4.6111 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.8634 -2.9778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8610 -2.1606 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.6942 -2.1606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4031 -1.7541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1129 -2.1693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8213 -1.7635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8242 -0.9454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1127 -0.5382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4072 -0.9431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1092 -2.9865 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
5 7 2 0
4 8 1 6
3 9 1 1
2 10 1 1
1 11 1 1
11 12 1 0
7 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
15 20 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 284.29Molecular Weight (Monoisotopic): 284.1172AlogP: -1.23#Rotatable Bonds: 3Polar Surface Area: 105.31Molecular Species: NEUTRALHBA: 5HBD: 5#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.52CX Basic pKa: 7.23CX LogP: -1.26CX LogD: -1.48Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.48Np Likeness Score: 0.24
References 1. Fan QH, Claunch KA, Striegler S.. (2014) Structure-activity relationship of highly potent galactonoamidine inhibitors toward β-galactosidase (Aspergillus oryzae)., 57 (21): [PMID:25295392 ] [10.1021/jm501111y ] 2. Pickens JB, Striegler S, Fan QH.. (2016) Arabinoamidine synthesis and its inhibition toward β-glucosidase (sweet almonds) in comparison to a library of galactonoamidines., 24 (16): [PMID:27298003 ] [10.1016/j.bmc.2016.04.069 ] 3. Pickens JB, Wang F, Striegler S.. (2017) Picomolar inhibition of β-galactosidase (bovine liver) attributed to loop closure., 25 (20): [PMID:28844803 ] [10.1016/j.bmc.2017.07.020 ]